L90.0
Conditions
Interventions
Group 1: The study population consists of 59 women with Lichen sclerosus et atrophicus, who were surgically treated in our department. Vulvectomy and subsequent reconstruction with the aOAP flap were
Sponsors
Luisenhospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All patients with therapy-refractory lichen sclerosus, who had presented themselves in our department between 2014 and 2022 and underwent surgical treatment, were retrospectively included in our study.
Exclusion criteria
Exclusion criteria: All of the previously mentioned patients were included retrospectively in our study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint includes the improvement in symptoms, specifically the reduction in dyspareunia and the restoration of the ability to engage in sexual intercourse. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoint includes the prevalence of postoperative complications with subsequent secondary intervention within one year. This includes, in particular, the occurrence of scar contractures, necroses, wound healing disorders or recurrence of Lichen sclerosus during the postoperative phase. Data was collected preoperatively and at intervals of three months, six months and one year postoperatively in the context of follow-up appointments. The evaluation was conducted retrospectively to investigate long-term effects. | — |
Countries
Germany
Contacts
Public ContactDan mon;Masih O'Dey;Kameh Khosh
Luisenhospital;Luisenhospital
Outcome results
None listed